Sunshine Biopharma, Inc. (SBFM)
0.243
+0.01
(+2.84%)
USD |
NASDAQ |
Oct 14, 16:00
0.2298
-0.01
(-5.43%)
After-Hours: 05:18
Sunshine Biopharma EPS Diluted (Quarterly) : -1.146 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.146 |
| March 31, 2026 | -2.535 |
| December 31, 2025 | -4.605 |
| September 30, 2025 | -1.940 |
| June 30, 2025 | -3.939 |
| March 31, 2025 | -4.364 |
| December 31, 2024 | -8.365 |
| September 30, 2024 | -0.945 |
| June 30, 2024 | -9.940 |
| March 31, 2024 | -40.04 |
| December 31, 2023 | -104.66 |
| September 30, 2023 | -50.72 |
| June 30, 2023 | -71.18 |
| March 31, 2023 | -154.52 |
| December 31, 2022 | -2082.06 |
| September 30, 2022 | -154.30 |
| June 30, 2022 | -68.00 |
| March 31, 2022 | -468.90 |
| December 31, 2021 | 102980.0 |
| September 30, 2021 | -3176.00 |
| June 30, 2021 | -2408.00 |
| March 31, 2021 | -5640.00 |
| December 31, 2020 | -1252.00 |
| September 30, 2020 | -996.00 |
| June 30, 2020 | -2372.00 |
| Date | Value |
|---|---|
| March 31, 2020 | -1040.00 |
| December 31, 2019 | -4480.00 |
| September 30, 2019 | -16960.00 |
| June 30, 2019 | -10480.00 |
| March 31, 2019 | -188000.0 |
| December 31, 2018 | -320000.0 |
| September 30, 2018 | -29.02M |
| June 30, 2018 | -1.024M |
| March 31, 2018 | -44800.00 |
| December 31, 2017 | -36800.00 |
| September 30, 2017 | -25600.00 |
| June 30, 2017 | -91200.00 |
| March 31, 2017 | -38400.00 |
| December 31, 2016 | -233600.0 |
| September 30, 2016 | -436800.0 |
| June 30, 2016 | -292800.0 |
| March 31, 2016 | -227200.0 |
| December 31, 2015 | -523200.0 |
| September 30, 2015 | -252800.0 |
| June 30, 2015 | -691200.0 |
| March 31, 2015 | -596800.0 |
| December 31, 2014 | -726400.0 |
| September 30, 2014 | -662400.0 |
| June 30, 2014 | -1.60M |
| March 31, 2014 | -1.60M |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.564M |
| Revenue (Quarterly) | 9.264M |
| Total Expenses (Quarterly) | 10.83M |
| Enterprise Value | -12.48M |
| Gross Profit Margin (Quarterly) | 25.35% |
| Profit Margin (Quarterly) | -16.88% |
| Earnings Yield | -4.21K% |
| Normalized Earnings Yield | -3775.93 |